Treatment & care
Finasteride Side Effects: What Doctors Often Don't Say
Finasteride side effects: what patients often aren't told—current risks, real experiences, and what recent studies show.
Finasteride side effects can be far more serious than many patients expect. A 2017 review of nearly 12,000 treatment cases found that 1.4% of men treated with finasteride developed persistent erectile dysfunction (PED). Especially concerning: younger men treated for longer than 205 days had about a fivefold higher risk of this lasting problem.
Although finasteride is often prescribed for hair loss and prostate issues, Germany's Federal Institute for Drugs and Medical Devices warns that some side effects can persist for more than ten years. The medical community groups these lasting problems under the term "post-finasteride syndrome" (PFS). However, this syndrome is not recognized as a standalone disease and many doctors are unfamiliar with it. This article explains which finasteride side effects can occur, why they are often underestimated, and what current studies tell us.
How Finasteride Works in the Body
Inhibition of 5-Alpha-Reductase
Finasteride is a synthetic steroid that acts as a competitive inhibitor of 5-alpha-reductase. This enzyme normally converts the male sex hormone testosterone into dihydrotestosterone (DHT). There are two subtypes of the enzyme: Type I and Type II. Finasteride primarily inhibits Type II. It competes with testosterone for the binding site on the enzyme, blocking the conversion.
Reduction of DHT in the Blood
This blockade substantially lowers DHT levels in the blood. Regular use of finasteride leads to an approximately 70% reduction in serum dihydrotestosterone concentration. That drop is notable because DHT is about five times more potent than testosterone and has stronger binding affinity and longer binding duration at the androgen receptor.
However, testosterone levels in the body generally remain normal despite finasteride use. That helps explain why many male body functions continue undisturbed, while others that depend more heavily on DHT are affected.
Effects on Hair Growth and the Prostate
In androgenetic alopecia (hereditary hair loss), hair follicles are hypersensitive to DHT. The hormone shortens the anagen (growth) phase of hair, so strands become thinner and eventually fall out. Men with this form of hair loss have miniaturized follicles and elevated DHT levels in the scalp.
By lowering DHT, finasteride can counteract this process. In about 80% of users, progressive hair loss is halted, and in about 65% hair growth is even strengthened.
Finasteride works similarly in prostate disease. DHT promotes growth of epithelial cells in the prostate, contributing to benign prostatic hyperplasia. By inhibiting DHT formation, finasteride reduces prostate volume by about 20% after roughly three months—and in some cases by as much as a third.
First visible results for hair usually appear only after 3–6 months of continuous use. Important: once treatment is interrupted, DHT levels rise again and the gains can reverse.
Common Side Effects of Finasteride
Finasteride treatment can cause significant adverse effects that every patient should know before starting therapy. While many doctors classify them as rare, newer studies paint a more nuanced picture.
Loss of Libido and Erectile Dysfunction
Sexual dysfunction ranks among the most frequently reported finasteride side effects. Affected men may experience reduced libido, erectile problems, and ejaculation difficulties. Especially worrying: these symptoms can appear not only during use but sometimes only after stopping the drug. Germany's medicines regulator even warns that such side effects can persist for more than ten years.
An analysis of electronic medical records found that 1.4% of 11,909 finasteride-treated patients developed persistent erectile dysfunction that lasted on average 1,348 days after discontinuation. Younger men under 42 who took finasteride for longer than 205 days had a 4.9-fold higher risk of this lasting disorder.
Breast Changes and Skin Reactions
Finasteride can also cause breast changes. Possible symptoms include:
- Breast enlargement (gynecomastia)
- Tenderness and tension pain
- Breast lumps
These changes were documented soon after the drug reached the market. About two years after its first introduction in Italy in 1992, roughly 250 cases of gynecomastia were observed. Skin reactions such as eczema or itching can also occur, though less often than sexual side effects.
Concerning, too: breast changes under finasteride can mask a possible male breast cancer.
Reduced Semen Volume
Finasteride can also affect semen production and quality. Many men experience reduced ejaculate volume. Although earlier studies found no impact on sperm quality, newer research suggests otherwise.
A study in men with fertility problems found that sperm concentration rose markedly after stopping finasteride—from an average of 13.2 to 42.25 million per ml of ejaculate. This suggests finasteride can significantly impair fertility in some men, especially those with pre-existing fertility issues.
Persistent Side Effects After Stopping
Especially alarming with finasteride are side effects that continue after the drug is discontinued. These persistent symptoms can impair affected men's lives for years.
What Is Post-Finasteride Syndrome?
Post-finasteride syndrome (PFS) describes a constellation of symptoms that appear during or after finasteride treatment and persist after stopping. Typical complaints include lasting sexual dysfunction, mental health problems, and cognitive impairment. Although the US FDA warned about persistent side effects as early as 2012, PFS is still not recognized as a standalone disease and remains unknown to many doctors.
Sexual Dysfunction for Months or Years
Especially concerning is how long sexual dysfunction can last. In a study of 11,909 patients, 1.4% developed persistent erectile dysfunction that on average only resolved 1,348 days (over 3.5 years) after stopping. Younger men under 42 who took finasteride longer than 205 days had a 4.9-fold higher risk. According to Germany's medicines institute, sexual dysfunction can even persist for more than ten years.
Mental Symptoms: Depression and Anxiety
Long-term mental side effects include depression, anxiety disorders, and in some cases suicidal thoughts. A pharmacovigilance study of 3,282 finasteride users found a disproportionately high occurrence of suicidality, depression, and anxiety in younger patients under 45. Since 2017, depression has been listed as a side effect in the product information.
Cognitive Impairment and Sleep Problems
Besides sexual and mental symptoms, many people with PFS report cognitive impairment. Sleep disturbances are also common—from difficulty falling asleep to night waking and insomnia despite fatigue. These symptoms can substantially reduce quality of life and make everyday activities harder.
Why Some Patients Are Especially Affected
Why some men develop PFS and others do not is not fully understood. Certain risk factors do seem to exist. Patients with a history of depression or sexual dysfunction carry elevated risk. Genetic factors also play a role—certain androgen receptor variants raise PFS risk sixfold. Possible mechanisms under discussion include hormonal dysregulation, epigenetic changes, and neurosteroidal dysfunction.
What Doctors Often Don't Say—and What You Should Know
Communication between doctors and patients about finasteride side effects often has major gaps. While the drug is prescribed routinely, important information frequently goes unmentioned.
Insufficient Counseling Before Prescription
Finasteride is an important medicine for androgenetic alopecia and prostate enlargement. Even so, patients are often not fully informed about possible side effects before treatment. About 8–18% of patients experience unwanted effects such as reduced libido, depression, and gynecomastia. Especially concerning is the practice of some doctors who prescribe the drug relatively casually—in some cases within only five minutes.
Lack of Recognition of PFS as a Clinical Entity
Although post-finasteride syndrome was added in early 2015 to the Genetic and Rare Diseases Information Center list of the US National Institutes of Health, that listing is explicitly not recognition that a disease called "post-finasteride syndrome" truly exists. Whether the syndrome exists remains unclear, because high-quality scientific studies that suggest or prove its existence are lacking.
Recommendations for Patients With Risk Factors
The UK medicines regulator (MHRA) recommends asking patients about a history of depression and suicidality before prescribing finasteride. Patients should also be monitored for psychiatric and sexual disorders. Use of finasteride in patients with a history of depression or sexual dysfunction should be considered especially carefully. Because those affected may not notice mental changes themselves, they should tell relatives or friends about the medication and its risks.
Duty to Report Adverse Drug Reactions
In both Germany and Switzerland there is a duty to report serious or previously unknown side effects. In Germany, a 2018 "Dear Doctor" letter informed physicians about psychiatric and sexual side effects of finasteride. Such reports are crucial to improve understanding of how often and how severe finasteride side effects really are. Patients can report side effects via www.akdae.de or using report forms regularly printed in the German Medical Journal.
Finasteride remains an effective medicine for hair loss and prostate enlargement. Scientific evidence clearly shows, however, that side effects can be considerably more serious and longer-lasting than previously assumed. Especially alarming is that younger men may carry a higher risk of persistent sexual dysfunction.
Insufficient counseling by doctors is a major problem. Many patients do not know before treatment that side effects such as erectile dysfunction, loss of libido, or depression can persist for years after stopping. Post-finasteride syndrome, though not yet fully recognized as a standalone diagnosis, describes a real problem for many people affected.
Anyone considering finasteride should therefore weigh all risks carefully. Potential benefits must be balanced against possible long-term side effects. Patients with a history of depression or sexual dysfunction should be especially cautious, as they carry elevated risk of lasting problems.
If side effects occur, contact your treating doctor promptly. Unwanted effects should also be reported to the relevant authorities to improve knowledge of the true frequency and severity of finasteride side effects.
Ultimately, the decision for or against finasteride rests with the patient—but an informed decision requires comprehensive information. That information should cover not only the benefits but also the risks that can last far beyond the treatment period.
